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Background: Little is known regarding the types of information African American and non-African American
patients with chronic kidney disease (CKD) and their families need to inform renal replacement therapy (RRT)
decisions.
Methods: In 20 structured group interviews, we elicited views of African American and non-African American
patients with CKD and their families about factors that should be addressed in educational materials informing
patients’ RRT selection decisions. We asked participants to select factors from a list and obtained their open-ended
feedback.
Results: Ten groups of patients (5 African American, 5 non-African American; total 68 individuals) and ten groups of
family members (5 African American, 5 non-African American; total 62 individuals) participated. Patients and families
had a range (none to extensive) of experiences with various RRTs. Patients identified morbidity or mortality,
autonomy, treatment delivery, and symptoms as important factors to address. Family members identified similar
factors but also cited the effects of RRT decisions on patients’ psychological well-being and finances. Views of
African American and non-African American participants were largely similar.
Conclusions: Educational resources addressing the influence of RRT selection on patients’ morbidity and mortality,
autonomy, treatment delivery, and symptoms could help patients and their families select RRT options closely
aligned with their values. Including information about the influence of RRT selection on patients’ personal
relationships and finances could enhance resources’ cultural relevance for African Americans.
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Patients’ decisions to select an initial renal replacement
therapy (RRT) for end-stage renal disease (ESRD) are
complex. The various forms of dialysis and transplant-
ation differ not only in their impacts on patients’ future
survival and quality of life [1-4], but also in important
characteristics which could influence patients’ preferences,
including treatment invasiveness [3,5], length of time for
treatment delivery [5], and treatment requirements for
self-care or family involvement [3]. Despite this, evidence
suggests patients are often not fully informed about the
availability of various RRT options or how these options
differ from one another, even when initiated under the
routine care of nephrologists [6-8]. Awareness of the avail-
ability and features of RRT options may be particularly
poor among African Americans, who have significantly
lower rates of initiating self-care treatment modalities such
as live kidney transplantation (LKT) when compared to
their non-African American counterparts [8,9].
Patients [10,11], nephrology professionals [12,13], and
policy makers [14] have recently begun to emphasize the
importance of informing patients about the risks and
benefits of various RRT options prior to their initiation.
There is also a growing interest in enhancing family in-
volvement in RRT selection decisions, as family mem-
bers often support and are affected by patients’ RRT
decisions [15]. Educational resources describing the fea-
tures, risks, and benefits of various medical treatment
alternatives are increasingly employed to help patients
and families make informed treatment choices [16-19]
and could help patients with chronic kidney disease
(CKD) better understand numerous considerations that
could influence their choice of RRT. To date, however,
little work has been done to identify the types of infor-
mation patients and families might value most. It is also
unclear whether African Americans’ and non-African
Americans’ preferences for information might differ.
We performed qualitative structured group interviews
among African American and non-African American
patients with CKD and their families to elicit their views
regarding information they felt should be featured in
educational resources informing RRT selection decisions.
Methods
Rationale and study design
Our overall goal was to identify the types of information
patients with CKD and families would view as important
to include in educational resources informing others’ RRT
selection decisions. We explored four a priori hypotheses
in our study. First, we hypothesized that patients and fam-
ilies would view a broad variety of factors as important
to include in educational resources. Second, we hypothe-
sized that patients’ perceived informational needs would
vary from those of family members, who would have lessdirect experience with RRTs and would experience RRT
mostly in the role of caregivers. Third, in light of well-
documented race differences in the types of RRTs initiated
in the U.S [6,9,20], we hypothesized that patients’ and
families’ informational needs might vary by race. Fourth,
we hypothesized patients with and without prior RRT ex-
perience would have different views about the types of in-
formation that might best inform RRT selection decisions.
For example, we hypothesized patients and families with
advanced CKD (non-dialysis dependent) who had not pre-
viously experienced RRTs might be concerned about tran-
sitioning to ESRD. In contrast, we hypothesized patients
and families who had previously experienced different
RRT modalities might articulate experiences related to re-
ceiving these modalities but might not recall concerns
they had prior to initiating RRT. We therefore gathered
separate groups of patients with different RRT experiences
(pre-ESRD, in-center hemodialysis, home hemodialysis,
peritoneal dialysis, or transplant) and family members,
and stratified groups by African American or non-African
American self-reported race. This provided a total of 20
structured groups (5 African American and 5 non-African
American patient groups, with one group per race for each
treatment experience; 5 African American and 5 non-
African American family member groups, with one group
per race for each treatment experience).
Study participants
We recruited study participants from community-based
and academic nephrology practices affiliated with dialy-
sis facilities as well as an academic kidney transplant
center in the Baltimore, Maryland metropolitan area
from September 2008 to July 2009. Participants were eli-
gible for participation if they spoke English, were at least
18 years of age, had advanced, progressive CKD as deter-
mined by their nephrologists (described as “pre-ESRD”),
had been on a RRT for at least a year prior to recruitment
in the study (in-center hemodialysis, home hemodialysis,
or peritoneal dialysis), or had received a kidney from a live
donor (transplant). Nephrology practices and the trans-
plant center provided us with lists of potentially eligible
participants. We first recruited patients for participation,
and then asked them to identify one family member or
friend (referred to as “family member”) involved in their
ESRD treatment decisions. All participants completed a
written questionnaire describing their demographic char-
acteristics and their relationship to patient participants (for
family members or friends). The Johns Hopkins School of
Medicine Institutional Review Board approved all proto-
cols and consent procedures.
Structured group interviews
We designed group interviews to obtain tabulated and
open-ended feedback from participants regarding their
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important to address in educational resources about
selecting RRTs. Trained moderators used standard guides
to conduct structured group interviews. Moderators pro-
vided each group participant with a written itemized list
of 36 factors reported by patients in prior studies to influ-
ence their RRT experiences [3,5,6,21]. All patients and
family members received the same list with the exception
of items specific to a RRT modality. For example, patients
and family members with kidney transplants received
items related to transplantation (e.g., “finding a living
donor” and “getting on the waiting list”) but not related to




Going to the hospital
Infections
Complications with surgery
Cancer (asked of Pre-ESRD and Transplant
groups only)
Making frequent trips to the doctor
Domain 2: Autonomy
Having children or getting pregnant
Control over treatment schedule
Doing the things I want to do when I want to do them
Going places by oneself
What I can eat or drink
Freedom and control over my life
Washing, dressing, eating and going to the toilet by
oneself
Doing usual activities
Domain 3: Treatment delivery
Blood tests, x-rays, and doctor visits
Pills that must be taken
Providing my own treatment
Surgery (asked of Pre-ESRD and Transplant
groups only)
Ordering and storing supplies at home
Surgery for fistulas or catheters (asked of Hemodialysis
and Peritoneal groups only)
Fistula or catheter problems (asked of Hemodialysis
and Peritoneal groups only)
The treatment (dialysis/transplant) going the way
expected
Getting on the waiting list (asked of Transplant
groups only)
Finding a living donor (asked of Transplant groups only)Domain 4: Symptoms







Having and enjoying sexual relations
How much family and friends need to help
Strains in ties with my family and friends
Making new friends
Domain 6: Psychological
Feeling sad, anxious, or stressed out
Domain 7: Finances
Money spent from my own pocket
Group interviews progressed through three stages. In
the first stage, moderators explained the purpose of the
interview and posed open-ended questions to probe par-
ticipants’ prior experiences with initiating RRT [22].
Moderators then provided each participant with the
itemized list of 36 factors and said, “Here is a list of fac-
tors patients who have kidney disease have said are im-
portant aspects of their kidney disease treatments.
Please spend the next few minutes choosing the 3 most
important aspects of treatment you think other patients/
families facing decisions about kidney disease treatments
should consider.” When addressing pre-ESRD groups,
the moderators slightly modified the latter half of the state-
ment and said, “If you/your family member were going to
choose a kidney disease treatment today, which 3 things
would you consider most important to you as you decide/
help your family member decide on one treatment to pur-
sue?” Moderators then asked all participants to circle three
factors (in no particular order) they felt were most import-
ant to address in educational resources about RRT. Once
participants circled three factors, the discussion progressed
to a second stage (referred to as round 1), in which mod-
erators asked each group participant to reveal their
selected factors and to discuss with others their rationale
for selections. In the third stage (referred to as round 2),
moderators asked participants to again circle three factors
they felt should be presented in educational resources
about RRT options, taking into account their feelings
about the group discussion from stage two. We audio-
recorded and transcribed all group discussions verbatim.
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We tallied the factors participants selected as important
during the third stage of discussions. We considered a
factor to be important if at least one participant
selected that factor within their respective group. We
described factors selected by groups and noted similar-
ities in factors selected across groups. In addition, three
trained investigators independently reviewed study
transcripts to identify quotes reflecting participants’ ra-
tionale surrounding commonly identified factors to
provide a context for their selection.Results
Participant characteristics
The 68 patient participants (37 African Americans,
31 non-African Americans) and 62 family members
(32 African Americans, 30 non-African Americans)
were demographically diverse. Most participants were
non-Hispanic and had health insurance. Family mem-
bers were comprised primarily of patients’ children,











Hispanic 0 (0) 0 (0) 1 (14) 0 (0) ¥
Race
White 0 (0) 5 (71) 0 (0) 8 (100
Black 6 (100) 0 (0) 7 (100) 0 (0)
Other 0 (0) 2 (29) 0 (0) 0 (0)
Age
Mean 54 58 56 65£
[Range] [28–69] [24–82] [27–65] [55–80
Gender
Female 5 (83) 2 (29) 3 (43) 4 (50)
Education
HS or less 3 (50) 0 (0) 0 (0) 4 (50)
At least two years of college 3 (50) 7 (100) 7 (100) 4 (50)
Marital Status
Married/ living with partner 0 (0) 6 (86) 1 (14) 6 (76)
Health Insurance
Insured 6 (100) 7 (100) 7 (100) 7 (87)†
*AA abbreviated for African American.
¥ Does not total to 100%; non-AA HD missing 3 (37), AA transplant missing 3 (28), n
€ Does not total to 100%; non-AA PD missing 1(25).
£Does not total to 100%; non-AA HD missing 1 (13), non-AA transplant missing 2 (1
† Does not total to 100%; non-AA HD missing 2 (25).Range of information most desired by African American
and non-African American patients
Patients frequently selected factors pertaining to
morbidity or mortality, autonomy, treatment delivery,
and symptoms as important to address in educational
resources about RRT selection decisions (Table 3).
Patients only mentioned factors on the predefined
lists provided to them and did not cite additional
factors.Morbidity or mortality
All ten patient groups (5 African American, 5 non-
African American) selected at least one factor pertaining
to the effect of RRT on patients’ morbidity or mortality.
Selections included “living longer” and “making frequent
trips to the doctor” (Table 3). A peritoneal dialysis pa-
tient explained:
“I think that’s something that everyone needs to know
that even though you do have kidney disease, it
doesn’t mean that it’s a lost cause; it doesn’t meanharacteristics













0 (0) 0 (0) 0 (0) 1 (25) 0 (0) ¥ 0 (0)¥
) 0 (0) 1 (100) 0 (0) 3 (75)€ 0 (0) 11 (100)
4 (100) 0 (0) 9 (100) 0 (0)€ 11 (100) 0 (0)
0 (0) 0 (0) 0 (0) 0 (0)€ 0 (0) 0 (0)
53 78 53 59 50 55£
] [38–75] [N/A] [33–69] [53–74] [37–61] [18–65]
1 (25) 0 (0) 6 (66) 0 (0) 6 (65) 8 (73)
1 (25) 0 (0) 2 (22) 3 (75) 4 (36) 2 (18)
3 (75) 1 (100) 7 (77) 1 (25) 7 (64) 9 (82)
3 (75) 0 (0) 2 (22) 3 (75) 8 (73) 8 (73)
4 (100) 1 (100) 9 (100) 4 (100) 11 (100) 11 (100)
on-AA transplant missing 2 (18).
8).
Table 2 African American and non-African American family member characteristics






















Hispanic 0 (0) ¥ 0 (0) 0 (0) 1 (14)¥ 0 (0) 1 (33) 0 (0) 1 (33)¥ 0 (0) 2 (18)¥
Race
White 0 (0) 6 (86) 0 (0) 6 (100) 0 (0)* 1 (33)* 0 (0) 2 (66) 0 (0) 10 (91)
Black 6 (100) 0 (0) 7 (100) 0 (0) 3 (100)* 0 (0)* 7 (100) 0 (0) 9 (100) 0 (0)
Other 0 (0) 1 (14) 0 (0) 0 (0) 0 (0)* 1 (33)* 0 (0) 1 (33) 0 (0) 1 (9)
Age
Mean [Range] 47€ 65€ 55 62.5 45€ 37€ 45 56 55.5 60
[29–63] [55–78] [46–67] [44–80] [37–52] [N/A] [45–75] [50–62] [39–68] [23–79]
Gender
Female 5 (83) 5 (71) 5 (71) 5 (83) 3 (100) 3 (100) 4 (57) 3 (100) 5 (55) 3 (27)
Education
HS or less 3 (50) 2 (29) 5 (71) 4 (67) 0 (0) 0 (0) 2 (28) 2 (66) 4 (44) 3 (27)
At least 2 years of college 3 (50) 5 (71) 2 (28) 2 (33) 3 (100) 3 (100) 5 (71) 1 (33) 5 (56) 8 (73)
Marital Status
Married/ living with partner 3 (50) 7 (100) 4 (57) 5 (83) 2 (67) 2 (67) 4 (57) 3 (100) 5 (56) 11(100)
Health Insurance
Insured 5 (83) 7 (100) 5 (71)† 6 (100) 3 (100) 3 (100) 7 (100) 3 (100) 9 (100) 11(100)
Relationship to Patient
Spouse 0 (0) 6 (86) 1 (14) 4 (67) 2 (67) 1 (33) 1 (14) 3 (100) 3 (33) 8 (73)
Parent/Parent-in-law 0 (0) 0 (0) 2 (28) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (22) 2 (18)
Child 2 (33) 1 (14) 1 (14) 1 (17) 0 (0) 0 (0) 0 (0) 0 (0) 1 (11) 0 (0)
Sibling 2 (33) 0 (0) 2 (28) 0 (0) 1 (33) 1 (33) 4 (57) 0 (0) 0 (0) 0 (0)
Cousin 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (22) 0 (0)
Other/Friend 2 (33) 0 (0) 0 (0) 1 (17) 0 (0) 1 (33) 2 (28) 0 (0) 1 (11) 1 (9)
*AA abbreviated for African American; ¥ Does not total to 100%; AA pre-ESRD missing 1 (17), AA HD missing 1 (17), AA PD missing 1 (14), AA transplant missing 1
(11); *Does not total to 100%, non-AA HHD missing 1 (33); € Does not total to 100%; AA pre-ESRD missing 1 (17), non-AA pre-ESRD missing 1 (14), AA HHD
missing 1 (33), non-AA HD missing 2 (67); † Does not total to 100%; AA HD family missing 1 (14).
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hopefully you can get a transplant. . . you definitely
can live longer” (non-African American patient,
peritoneal dialysis).
Autonomy
Similarly, all ten patient groups (5 African American, 5
non-African American) also selected at least one factor
pertaining to the effect of RRT on patients’ autonomy.
Selections included “doing things I want to do when I
want to do them” and “freedom and control over my
life” (Table 3). One participant noted:
“I can’t work. I was a senior executive for a national
company and 80% of my time was spent in other
states, and I can’t do that anymore. . .you can’t be atop executive and only work three days a week” (non-
African American patient, in-center hemodialysis).
Treatment delivery
Nine patient groups (5 African American, 4 non-African
American) selected at least one factor pertaining to
patients’ experiences with initiating RRT treatment de-
livery. Selections included “finding a living donor” and
“fistula or catheter problems” (Table 3). One patient par-
ticipant commented:
“When I first started, a lot of patients that I met
didn’t understand what the differences between the
fistula and the catheter was, why, what was the
purpose of either, and I just think that’s something
they need to educate us on more for when you are a
Table 3 Patients’ and family members’ factors to address in educational resources about RRT selection decisions
Ranking round* All patients n(%)** All family members n(%)**
AA Non-AA AA Non- AA
N=37 N=31 N=32 N=30
Morbidity/Mortality
Living Longer 1 30 (81) 22 (71) 22 (69) 23 (77)
2 22 (59) 21 (68) 17 (53) 23 (77)
Going to the hospital 1 6 (16) 3 (10) 2 (6) 2 (7)
2 2 (5) 2 (6) 1 (3) 0 (0)
Infections 1 2 (5) 5 (16) 10 (31) 6 (20)
2 1 (3) 3 (10) 7 (22) 3 (10)
Complications with surgery 1 1 (3) 2 (6) 4 (13) 2 (7)
2 0 (0) 2 (6) 3 (9) 1 (3)
Cancer 1 2 (5) 1 (3) 0 (0) 0 (0)
2 0 (0) 2 (6) 0 (0) 0 (0)
Making frequent trips to the doctor 1 1 (3) 0 (0) 1 (3) 2 (7)
2 5 (14) 1 (3) 2 (6) 1 (3)
Autonomy
Having children or getting pregnant 1 0 (0) 0 (0) 2 (6) 2 (7)
2 0 (0) 0 (0) 3 (9) 2 (7)
Control over treatment schedule 1 6 (16) 5 (16) 6 (19) 4 (13)
2 2 (5) 5 (16) 2 (6) 3 (10)
Doing the things I want to do when I want to do them 1 10 (27) 11 (35) 10 (31) 7 (23)
2 7 (19) 13 (42) 6 (19) 7 (23)
Going places by oneself 1 5 (14) 3 (10) 2 (6) 1 (3)
2 1 (3) 2 (6) 0 (0) 1 (3)
What I can eat or drink 1 4 (11) 4 (13) 4 (13) 5 (17)
2 4 (11) 4 (13) 5 (16) 6 (20)
Freedom and control over my life 1 14 (38) 8 (26) 10 (31) 14 (47)
2 6 (16) 7 (23) 8 (25) 14 (47)
Washing, dressing, eating, and going to the toilet by myself 1 1 (3) 1 (3) 0 (0) 2 (7)
2 0 (0) 1 (3) 1 (3) 2 (7)
Doing usual activities 1 3 (8) 3 (10) 2 (6) 5 (17)
2 4 (11) 3 (10) 5 (16) 6 (20)
Delivery
Blood tests, x-rays, and doctors visits 1 3 (8) 3 (10) 2 (6) 6 (20)
2 0 (0) 3 (10) 0 (0) 6 (20)
Pills that must be taken 1 4 (11) 4 (11) 1 (3) 7 (23)
2 3 (8) 4 (13) 1 (3) 8 (27)
Providing my own treatment 1 6 (16) 3 (10) 2 (6) 0 (0)
2 3 (8) 1 (3) 1 (3) 1 (3)
Surgery 1 2 (5) 1 (3) 0 (0) 1 (3)
2 0 (0) 1 (3) 0 (0) 0 (0)
Ordering and storing supplies at home 1 2 (5) 0 (0) 1 (3) 2 (7)
2 3 (8) 0 (0) 1 (3) 1 (3)
Surgery for fistulas or catheters 1 1 (3) 1 (3) 1 (3) 1 (3)
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Table 3 Patients’ and family members’ factors to address in educational resources about RRT selection decisions (Continued)
2 1 (3) 3 (10) 1 (3) 1 (3)
Fistula or catheter problems 1 3 (8) 1 (3) 0 (0) 0 (0)
2 3 (8) 1 (3) 1 (3) 1 (3)
The treatment going as expected 1 1 (3) 2 (6) 2 (6) 3 (10)
2 4 (11) 2 (6) 0 (0) 2 (7)
Getting on the waiting list 1 0 (0) 2 (6) 1 (3) 1 (3)
2 0 (0) 2 (6) 0 (0) 0 (0)
Finding a living donor 1 3 (8) 3 (10) 4 (13) 7 (23)
2 0 (0) 4 (13) 4 (13) 8 (27)
Symptoms
Itching, cramping, or aching 1 2 (5) 1 (3) 1 (3) 0 (0)
2 2 (5) 1 (3) 0 (0) 0 (0)
Thinking clearly 1 5 (14) 4 (13) 5 (16) 0 (0)
2 2 (5) 7 (23) 2 (6) 0 (0)
Feeling tired 1 1 (3) 3 (10) 3 (9) 3 (10)
2 5 (14) 2 (6) 3 (9) 3 (10)
Gaining weight 1 1 (3) 2 (6) 0 (0) 0 (0)
2 1 (3) 5 (16) 1 (3) 0 (0)
Losing weight 1 0 (0) 1 (3) 0 (0) 0 (0)
2 1 (3) 0 (0) 2 (6) 0 (0)
Pain 1 2 (5) 0 (0) 4 (13) 2 (7)
2 1 (3) 0 (0) 4 (13) 6 (20)
Relationships
Having and enjoying sexual relations 1 1 (3) 0 (0) 1 (3) 1 (3)
2 0 (0) 0 (0) 5 (16) 2 (7)
How much family and friends need to help 1 8 (22) 1 (3) 4 (13) 0 (0)
2 1 (3) 1 (3) 4 (13) 0 (0)
Strains in ties with my family and friends 1 1 (3) 1 (3) 0 (0) 0 (0)
2 1 (3) 0 (0) 1 (3) 0 (0)
Making new friends 1 0 (0) 0 (0) 0 (0) 0 (0)
2 2 (5) 0 (0) 1 (3) 0 (0)
Psychological
Feeling sad, anxious, stressed out 1 1 (3) 2 (6) 3 (9) 1 (3)
2 2 (5) 1 (3) 3 (9) 2 (7)
Finance
Money spent from my own pocket 1 2 (5) 1 (3) 3 (9) 0 (0)
2 1 (3) 1 (3) 2 (6) 1 (3)
*Participants rankings in round 1 constituted “Stage 2” of the mixed methods study; rankings in round 2 constituted “Stage 3” of the mixed methods study;
**Percentage of total persons among groups provided with this option to consider.
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peritoneal dialysis).
Symptoms
Five patient groups (2 African American, 3 non-African
American) selected at least one factor pertaining to theinfluence of RRT on symptoms patients might experience.
Selections included “thinking clearly” and “itching, cramp-
ing, or aching” (Table 3). One patient participant explained:
“There needs to be more awareness of what happens
to a person leading up to kidney failure because if I
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was suffering from and why that was happening, I
would have sought treatment sooner and I might not
have almost died” (non-African American patient,
peritoneal dialysis).
Relationships
Three African American patient groups selected factors
pertaining to the influence of RRT on personal relation-
ships. Selections included “family and friends need to help”
and “making new friends” (Table 3). None of the non-
African American patient groups selected this factor. One
participant stated:
“Friendship comes because we are all in the same boat.
We know that everybody needs somebody sometimes.
And the good part about it is that we can rely and we
can converse, nobody gets angry, nobody gets upset”
(African American patient, in-center hemodialysis).
Range of information most desired by African American
and non-African American family members
Similar to patients, both African American and non-
African American family members most frequently selected
factors pertaining to the effect of RRT on patients’ morbid-
ity or mortality, autonomy, experiences with treatment de-
livery, and their symptoms as important to address in
educational resources. Within domains, family members
sometimes chose different factors than patients. Family
members also more frequently discussed the influence of
RRT selection on patients’ psychological well-being and
finances (Table 3). Family members only identified factors
on the predefined list provided to them and did not cite
additional factors.
Morbidity or mortality
All ten family member groups (5 African American, 5
non-African American) selected at least one factor per-
taining to the effect of RRT on patients’ morbidity or mor-
tality. Selections included “living longer” and “infections”
(Table 3). A peritoneal dialysis family member explained:
“You have to know that dealing with the kidneys and
the treatments and things that there are infections
that you have to worry about. You need information
on how you can handle it and move on” (African
American family member, peritoneal dialysis).
Autonomy
Eight family member groups (4 African American, 4
non-African American) chose at least one factor pertain-
ing to the effect of RRTs on patients’ autonomy. Selec-
tions included “freedom and control over my life” and
“what I can eat or drink” (Table 3).One family member commented:
“He wanted to continue to eat the way he had always
eaten and I mean I sat day and night reading
everything. When we went to the market I had my list
to say this is what you can eat, this is what you can’t
because he still wanted to eat lunch meats, anything
that was high in salt, and you know we almost had a
bad one” (African American family member, in-center
hemodialysis).
Treatment delivery
Four family member groups (2 African American, 2
non-African American) selected at least one factor per-
taining to patients’ experiences with initiating RRT treat-
ment delivery. Selections included “finding a living
donor” and “ordering/storing supplies at home” (Table 3).
One family member noted:
“There’s a lot of boxes-there’s a lot of supplies that
come in, all the medical stuff. If you have not
prepared for all that’s involved in getting your dialysis
treatment delivered into your home and the influx of
materials that’s coming in it can be very cumbersome.
I think it’s important that people are aware of the
types of things that are going to come in and the full
scope of what has to be done - you have to rearrange
your home” (African American family member,
peritoneal dialysis).
Symptoms
Four family member groups (3 African American, 1
non-African American) chose at least one factor pertain-
ing to the influence of RRT on symptoms patients might
experience. Selections included “feeling tired” and “pain”
(Table 3). One family member stated:
“It’s something that I think is important to know
about beforehand, what to expect, and thinking along
the lines of either dialysis or transplant, whatever one,
how much pain is involved and how much discomfort
there is going to be” (African American family
member, pre-ESRD).
Relationships, psychological well-being, and finances
Three African American family member groups identified
factors pertaining to patients’ relationships as important
factors to address in educational resources about RRT se-
lection. Selections included “family and friends need to
help” and “having and enjoying sexual relations.” None of
the non-African American family member groups selected
these factors. Two groups (1 African American, 1 non-
African American) also selected a factor pertaining to the
psychological impact of RRT selection (i.e., “feeling sad,
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(but no non-African American groups) chose a factor per-
taining to the influence of RRT on personal finances
(Table 3). One family member described the psychological
impact her family member experienced while facing the
need to make a decision about RRT initiation:
“She feels that dialysis is the end of anybody’s life.
Once you go on dialysis, that is it, there is nothing
left. She knows so many people that had it and then
they die, so she is fearful and angry about that”
(African American family member, pre-ESRD).
Evaluation of differences in information needs by race
and experience with ESRD treatments
We did not detect substantial differences in participants’
reported information needs according to their race or
ethnicity (Table 3). In analyses exploring differences in
information needs among patients with varying experi-
ences on ESRD therapies, patients with no prior experi-
ence reported they felt it important to have educational
resources address a broader range of factors compared
to patients with experience on various treatments for
ESRD (Additional file 1: Appendix Tables 1 and 2).
Effect of discussions on participants’ perceived
information needs
Discussion among participants between rounds 1 and 2
of the ranking exercise did not appear to substantially
change their perceived information needs. However, par-
ticipants did seem to shift their ranking somewhat after
round 1 discussions. For example, more patients and
family members ranked “living longer” as important to
feature in educational resources in the first round than
in the second round (Table 3).
Discussion
Educational resources addressing factors that patients
and families deem most important to their decisions
regarding RRT could facilitate a RRT selection well-
aligned with their personal values. In this study, patients
with CKD and their families most frequently viewed in-
formation on how RRTs affect patients’ morbidity or
mortality, autonomy, experiences with treatment deliv-
ery, symptoms, personal relationships, psychological well-
being, and finances as important factors to address in
educational resources informing RRT selection decisions.
Family members additionally identified information on
how RRTs affect patients’ psychological well-being and
finances. Most findings were similar between African
American and non-African American patients and fam-
ilies. However, African American patients and families
more frequently identified the influence of RRTs onpersonal relationships and finances as important factors
to address compared to non-African Americans.
To our knowledge, this is the first US study to explore
ethnic/race differences in the types of information patients
and their families feel should be included in educational
resources to support RRT decisions. While prior studies
have informed the development of educational resources
for patients related to CKD care [23] and the transition to
traditional dialysis therapies (i.e., hemodialysis and peri-
toneal dialysis) [24], they have not specifically focused on
identifying key information that would help patients and
families understand critical differences between a range of
RRT modalities, including home hemodialysis or trans-
plantation [3,25]. They have not also sought to identify
factors that might enhance the cultural relevance of
materials for African Americans or other minority groups.
Our findings suggest that family members may broaden
the range of considerations influencing RRT decisions be-
yond considerations commonly expressed by patients.
Family members may provide both psychological and cog-
nitive support during the decision-making process and are
also likely to play significant caregiver roles (e.g., providing
transportation to dialysis and medical appointments).
Efforts to include information about factors deemed im-
portant to family members could not only help families
better understand the health risks and benefits of various
RRTs but may also help them set reasonable expectations
regarding the logistical and psychological burden certain
RRT choices may place on patients’ families.
Our findings also highlight the potential importance
of tailoring educational resources to meet the needs of
patients and their families based on their prior experi-
ences with ESRD treatments. For instance, we found
that patients with no experience on ESRD treatments
expressed interest in a broader range of topics when
compared to their counterparts who had prior experi-
ence with therapies. Patients with no prior experience
with ESRD treatments may need extensive education on
how ESRD and its treatments could impact multiple
aspects of their lives, while patients with treatment ex-
perience may need more focused information about
how treatment alternatives might change their treatment
experiences. Notably, our participants’ group discussions
may have influenced their final rankings of factors they
felt should be important to include in educational materi-
als. For instance, more participants rated “living longer” as
important to discuss in educational materials during the
first round of ranking compared to the second round of
ranking. It is possible discussion of the importance of vari-
ous factors pertaining to treatment experience may have
encouraged our participants to consider more patient-
centered aspects of treatment (e.g., such as the influence
of treatments on patients’ relationships) that could influ-
ence others’ treatment choices.
DePasquale et al. BMC Nephrology 2013, 14:9 Page 10 of 11
http://www.biomedcentral.com/1471-2369/14/9Limitations of our study deserve mention. First, the
experiences of patients recruited in Baltimore, Maryland
may not generalize to the experiences of other patients
with ESRD and their families, or individuals from differ-
ent geographic areas. Because we recruited patients re-
ceiving RRT for more than a year, it is probable that
patients’ recall concerning decision making about RRT
initiation could have changed over time. It is also likely
patients’ recollections regarding initiation of a single
RRT could have been altered since there were some par-
ticipants who had experience with more than one treat-
ment modality. Second, some of our patient and family
groups were small and may not have elicited the full
range of factors considered important to more represen-
tative groups of patients and families. Many contextual
factors could influence patients’ and their family mem-
bers’ perceived information needs, including their educa-
tion levels, financial resources, available family support,
and independence. Family members’ perceived informa-
tion needs might also vary according to the closeness of
their relationships with patients. Moreover, the total
number of participants in our groups was small, limiting
our ability to make inferences regarding whether partici-
pants’ information needs might vary according to these
factors. Our findings of potential differences between Af-
rican American and non-African American groups could
be influenced by differences in the education or financial
status of participants and should therefore be interpreted
with caution. Finally, we asked patients to identify one
family member to participate in our study. The perspec-
tives of the family members chosen to participate may
have differed from the viewpoints of non-participants.
Notwithstanding these limitations, we are unaware of
other studies designed to simultaneously identify patients’
and families’ needs regarding education to support RRT
selection decisions. Furthermore, we are not aware of
studies exploring potential race differences in these needs.
Conclusions
African American and non-African American patients with
CKD and their families reported that educational resources
informing RRT decisions should include information on
how RRTs could affect patients’ morbidity or mortality, au-
tonomy, experiences with RRT delivery, symptoms, psy-
chological well-being, personal relationships and finances.
Educational resources addressing these factors could help
ensure patients’ and families’ RRT selection decisions are
well-aligned with their personal values.
Additional file
Additional file 1: Appendix Table 1. Patients’ factors to address in
educational resources about RRT selection decisions. Table 2. Family members’
factors to address in educational resources about RRT selection decisions.Abbreviations
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